PUNE, India, June 13, 2018 /PRNewswire/ --
ReportsnReports.com adds the wound debridement market is expected to reachUSD 1,041 million by 2023 from USD 702 million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of
Browse 104 Market Data Tables and 26 Figures spread through 129 Pages and In-depth TOC on "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" at http://www.reportsnreports.com/reports/1521199-wound-debridement-market-by-product-gels-ointments-surgical-ultrasonic-devices-method-autolytic-enzymatic-mechanical-wound-type-venous-leg-diabetic-foot-pressure-ulcers-burns-end-user-hospitals-cl-st-to-2023.html .
The major players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mölnlycke Health Care AB (Sweden), and Integra LifeSciences (US).
The wound debridement market has been segmented into autolytic, enzymatic, surgical, mechanical, and other methods. In 2018, the autolytic methods segment is expected to register the largest market share during the forecast period. The large share of this segment is primarily due to its advantages-no damage to healthy tissue and ease of use.
Inquire for Discount on "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1521199 .
Geographically, the wound debridement market is dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to the increasing awareness regarding advanced treatment methods, increasing patient population, and the presence of emerging economies such as China and India.
The report analyses the wound debridement market by product, wound type, method, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market.
2 Market Share Analyses
3 Competitive Situation and Trends
5 Product Launches
The global wound debridement market is segmented by product, wound type, method, end user, and region. Based on products, the wound debridement market is segmented into gels, ointments & creams, surgical devices, ultrasound devices, mechanical debridement pads, medical gauzes, and other wound debridement products. Of all these product segments, gels accounted for the largest share of the market in 2017.
Order a Copy of "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" research report at http://www.reportsnreports.com/purchase.aspx?name=1521199.
The global wound debridement market is dominated by North America, followed by Europe. North America will continue to dominate the global wound debridement market in the forecast period. However, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. Growth in this market is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
The primary interviews conducted for this report can be categorized as follows:
Another research titled the wound care biologics market is expected to reach USD 2.26 billion by 2023 from USD 1.42 billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. The major players in this market are Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and Marine Polymer Technologies, Inc. (US) now available at http://www.reportsnreports.com/purchase.aspx?name=1526531.
Explore more reports on Medical Devices Market Research at http://www.reportsnreports.com/market-research/medical-devices/.
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact: Hrishikesh Patwardhan 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411001. Maharashtra, India. +1-888-391-5441 firstname.lastname@example.org
Connect with Us:
RSS/Feeds: http: //www.reportsnreports.com/feed/l-latestreports.xml
Subscribe to our Free Newsletters!